Skip to content

Cardiac Rehabilitation and Noninvasive Ventilation in Heart Failure

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02811146
Enrollment
20
Registered
2016-06-23
Start date
2016-07-31
Completion date
2021-07-01
Last updated
2021-10-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Heart Failure

Keywords

Heart Failure, Noninvasive Ventilation, Positive- Pressure Respiration

Brief summary

The study aims to demonstrate the efficacy of NIV continuously in cardiac rehabilitation programs, improvement of exercise tolerance, with consequent reflection in functional capacity and quality of life of this population.

Detailed description

BACKGROUND: Heart failure (HF) is a cardiovascular syndrome with enormous impact on public health by high morbidity and mortality rates that are associated. Studies show that changes in striated skeletal muscle of those individuals, possibly caused by progressive physical inactivity, contribute to the construction of the pathophysiology of this disease, emphasizing the importance of exercise for these patients. Exercise programs can be traced safer and related form the actual functional capacity thereof. Cardiac rehabilitation it is a set of activities that aims to ensure that patients with heart disease the best conditions, especially physical. In this context, non-invasive ventilation (NIV) is an alternative to provide an improved tolerance during exercise in patients with HF. GOALS: Evaluate the effectiveness of the use of NIV association to aerobic exercise in exercise programs supervised during cardiac rehabilitation exercise tolerance and quality of life in patients with heart failure when compared to performing these exercises without ventilatory support. METHODS: This is a clinical trial, controlled, randomized and blind to be developed with patients arising out of the main Recife reference centers in the care of patients with heart failure. It will be conducted assessments of functional capacity made by cardiopulmonary exercise testing (CPET), the Glittre-ADL test and through the questionnaire Duke Activity Status Index (DASI), assessment of quality of life using the questionnaire Minnesota Living with Heart Failure (MLWHF), and finally, in order to determine a clinical change, will be used to Patient Global Impression of Change Scale (PGIS). EXPECTED RESULTS: This study aims to demonstrate the efficacy of NIV continuously in cardiac rehabilitation programs, improvement of exercise tolerance, with consequent reflection in functional capacity and quality of life of this population.

Interventions

DEVICEBilevel Positive Pressure Airway

Heart rehabilitation with noninvasive ventilation, for 12 weeks, 3 times a week

OTHERHeart rehabilitation

Heart rehabilitation, for 12 weeks, 3 times a week

Sponsors

Universidade Federal de Pernambuco
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
21 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* Sedentary adults diagnosed with heart failure of ischemic hypertensive or alcoholic etiology; * Ejection fraction of the left ventricle smaller than 50% (LVEF \<50%) assessed by echocardiography simple; * Recent and functional class II and III by the New York Heart Association (NYHA); * FEV1 \<80% predicted and / or FEV1 / FVC\> 70% predicted; * Clinical stability; Ex-smokers for more than five years; * No change in the class of drugs within three months prior to the beginning of the study.

Exclusion criteria

* Patients with unstable angina; * Myocardial infarction or heart surgery up to three months before the survey; * FEV1 / FVC \<70% predicted characterizing obstructive respiratory disorder; * Respiratory diseases; * Smoking; * Hemodynamic instability; * Trauma of recent face; * Nausea and vomiting; * Orthopedic and neurological diseases; * Psychic changes that restrict them to respond to the questionnaire.

Design outcomes

Primary

MeasureTime frameDescription
Cardiopulmonary exercise testingBaseline and 12 weeksChange in functional capacity
Glittre-ADL TestBaseline and 12 weeksChange in submaximal functional capacity
Six-Minute Walk TestBaselineChange in submaximal functional capacity
Ventilatory metabolic response during the 6-minute walk test (6MWT) and Glittre-ADL TestBaseline and 12 weeksCompare the ventilatory metabolic response of the six-minute walk test and Glittre-ADL Test

Secondary

MeasureTime frameDescription
Minnesota Living with Heart FailureBaseline and 12 weeksImproved in quality of life
Bioimpedance scaleBaseline and 12 weeksChange in the body composition

Countries

Brazil

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026